Rare diseases
Investigational molecules
Locations
Back to Poland2 clinical trials in Brodnica, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandPolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on atherosclerotic cardiovascular disease in patients with end-stage kidney disease. These studies aim to evaluate novel therapeutic approaches for patients undergoing dialysis treatment.
Research centers around investigating the effectiveness of treatments in reducing C-reactive protein levels, an important marker of inflammation in cardiovascular disease among dialysis patients.
Specialized research examining treatment options for patients with end-stage kidney disease (ESKD), with particular attention to cardiovascular complications in this population.
The trials explore intravenous therapeutic interventions aimed at improving outcomes for dialysis patients with cardiovascular complications.
Studies focusing on the role of inflammation in cardiovascular complications among dialysis patients, evaluating novel approaches to reduce inflammatory markers.
Research combines dose-finding objectives with cardiovascular outcome measurements to optimize treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
